Neuronetics Inc.(STIM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

STIM Neuronetics Inc.

Market Closed 12-12 16:00:00 EST

1.52

+0.15

+10.95%

盘后1.52

+0.000.00%

19:50 EST

High1.60	Low1.34	Vol2.69M
Open1.36	D1 Closing1.37	Amplitude18.42%
Mkt Cap104.10M	Tradable Cap65.69M	Total Shares68.49M
T/O4.07M	T/O Rate6.21%	Tradable Shares43.21M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"STIM","market":"US","secType":"STK","nameCN":"Neuronetics Inc.","latestPrice":1.52,"timestamp":1765573200000,"preClose":1.37,"halted":0,"volume":2685217,"hourTrading":{"tag":"盘后","latestPrice":1.52,"preClose":1.52,"latestTime":"19:50 EST","volume":2327,"amount":3537.335,"timestamp":1765587022301},"delay":0,"floatShares":43213900,"shares":68485922,"eps":-0.766743,"marketStatus":"Market Closed","change":0.15,"latestTime":"12-12 16:00:00 EST","open":1.36,"high":1.595,"low":1.3427,"amount":4065520.8447677,"amplitude":0.184161,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.766743,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1530158400000,"exchange":"NASDAQ","adjPreClose":1.37,"preHourTrading":{"tag":"盘前","latestPrice":1.4,"preClose":1.37,"latestTime":"08:46 EST","volume":1054,"amount":1454.5999986,"timestamp":1765547160177},"postHourTrading":{"tag":"盘后","latestPrice":1.52,"preClose":1.52,"latestTime":"19:50 EST","volume":2327,"amount":3537.335,"timestamp":1765587022301},"volumeRatio":4.2985260365335165,"impliedVol":2.5712,"impliedVolPercentile":0.916},"requestUrl":"/m/hq/s/STIM","defaultTab":"news","newsList":[{"id":"2588053241","title":"TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen","url":"https://stock-news.laohu8.com/highlight/detail?id=2588053241","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588053241?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:00","pubTimestamp":1764680400,"startTime":"0","endTime":"0","summary":"ROCKAWAY, N.J., Dec.  02, 2025  (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced the publication of a peer rev","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197870/0/en/TAC-STIM-Demonstrates-Significant-Performance-Improvements-in-Active-Duty-United-States-Air-Force-Airmen.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UBCP","STIM","BK4082","BK4105","BK4211","TAC","MQT"],"gpt_icon":0},{"id":"2582033703","title":"TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2582033703","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582033703?lang=en_us&edition=fundamental","pubTime":"2025-11-12 23:33","pubTimestamp":1762961580,"startTime":"0","endTime":"0","summary":"New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 StatesMALVERN, Pa., Nov.  12, 2025  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technolo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186484/0/en/TRICARE-West-Expands-NeuroStar-TMS-Coverage-to-Include-Adolescents-Aged-15-Struggling-with-Depression.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","STIM","BK4082","ABVC"],"gpt_icon":0},{"id":"2580731098","title":"Neuronetics President, CEO Keith Sullivan to Retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2580731098","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580731098?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:59","pubTimestamp":1762261140,"startTime":"0","endTime":"0","summary":"Neuronetics's president and chief executive, Keith Sullivan, plans to retire from the medical-technology and healthcare company next year.Neuronetics on Tuesday said Sullivan, who has been at the helm of the Malvern, Pa., company since July 2020, will retire at the end of June.Neuronetics said it has launched a search for a new CEO, adding that Sullivan has agreed to remain as a consultant to assist with the transition.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STIM","BK4082"],"gpt_icon":0},{"id":"2580381739","title":"Neuronetics Inc. Showcases Growth Strategy and Mental Health Solutions in Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2580381739","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580381739?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:31","pubTimestamp":1762259510,"startTime":"0","endTime":"0","summary":"Neuronetics Inc. has released a corporate presentation outlining its recent merger with another major mental health and device company, creating a vertically integrated organization focused on expanding access to mental health treatments. The combined entity reported $129 million in annual revenue for 2024, treated 229,429 unique patients, and administered over 8.2 million treatments. The company highlighted its diversified business model, leveraging expertise in both transcranial magnetic stimulation  through its NeuroStar brand and mental health services via Greenbrook. Senior leadership includes President and CEO Keith Sullivan and Chief Financial Officer Steven Pfanstiel. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL5VBnfk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506951958.HKD","LU2461242641.AUD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU1791710400.SGD","BK4554","LU0238689110.USD","LU1923622614.USD","LU2592432038.USD","LU0267386448.USD","LU0390134368.USD","LU1043141396.HKD","LU2491050154.USD","LU1642822529.SGD","LU1221951046.USD","LU2506952170.USD","IE00B19Z8X17.USD","LU1791710582.SGD","LU2491049909.HKD","IE00BQXX3D17.EUR","LU0187121727.USD","LU2491050071.SGD","LU2065171402.SGD","SGXZ51526630.SGD","LU1989763005.USD","LU0708995401.HKD","LU2065171311.SGD","LU0157215616.USD","IE00B1XK9C88.USD","LU0061475181.USD","IE00BK4W5L77.USD","IE00BK4W5M84.HKD","IE0004086264.USD","LU0056508442.USD","LU1221951129.SGD","LU2506952097.USD","LU0215105999.USD","LU1066051498.USD","LU1551013342.USD","LU1852331112.SGD","LU1496350171.SGD","BK4548","LU0342679015.USD","SG9999014575.USD","STIM","LU0314104364.USD","LU1196500208.SGD","LU0312595415.SGD","LU0225283273.USD"],"gpt_icon":1},{"id":"2580736888","title":"Neuronetics Q3 revenue misses estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2580736888","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580736888?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:14","pubTimestamp":1762258440,"startTime":"0","endTime":"0","summary":"Neuronetics Q3 revenue misses estimatesOverviewNeuronetics Q3 2025 revenue rose 101% yr/yr but missed analyst expectationsU.S. Greenbrook clinic revenue grew 25% on an adjusted pro forma basisCEO Keit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL1N3WG0JS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","BK4585","NLY","BK4588","BK4082","STIM"],"gpt_icon":0},{"id":"2580926735","title":"Neuronetics Q3 EPS $(0.13) Misses $(0.10) Estimate, Sales $37.297M Miss $38.055M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2580926735","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580926735?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:06","pubTimestamp":1762257996,"startTime":"0","endTime":"0","summary":"Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.10) by 26.21 percent. This is a 70.45 percent increase over losses of $(0.44) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48616549/neuronetics-q3-eps-0-13-misses-0-10-estimate-sales-37-297m-miss-38-055m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","STIM"],"gpt_icon":0},{"id":"2580735669","title":"BRIEF-Neuronetics Q3 Gross Margin 45.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580735669","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580735669?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:05","pubTimestamp":1762257946,"startTime":"0","endTime":"0","summary":"BRIEF-Neuronetics Q3 Gross Margin 45.9%\n\n\nNov 04 (Reuters) - Neuronetics Q3 EPS USD -0.13.\n\nQ3 operating expenses USD 24.4 million\noutlook Q4 revenue USD 40-43 million\noutlook FY revenue USD 147-150 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX4C5826:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","STIM"],"gpt_icon":0},{"id":"2580735677","title":"Neuronetics Inc - CEO Keith J. Sullivan to Retire June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2580735677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580735677?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:05","pubTimestamp":1762257901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX4C5826:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STIM","BK4082"],"gpt_icon":0},{"id":"2580676735","title":"Neuronetics Outlook Q4 Revenue USD 40-43 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2580676735","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580676735?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:05","pubTimestamp":1762257901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX4C5826:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STIM","BK4082"],"gpt_icon":0},{"id":"2580629735","title":"Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2580629735","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580629735?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:05","pubTimestamp":1762257901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUA5QKK39:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STIM","BK4082"],"gpt_icon":0},{"id":"2580195416","title":"Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580195416","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580195416?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:30","pubTimestamp":1761942600,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Oct.  31, 2025  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/31/3178647/0/en/Neuronetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","SQQQ","BK4139",".IXIC","ABVC","STIM","QID","NQmain","PSQ","TSYW.SI","QLD","USAW.SI","BK4082","USJW.SI","NVIW.SI","MNQmain"],"gpt_icon":1},{"id":"2579146064","title":"Neuronetics Inc  expected to post a loss of 13 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2579146064","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579146064?lang=en_us&edition=fundamental","pubTime":"2025-10-31 21:47","pubTimestamp":1761918427,"startTime":"0","endTime":"0","summary":"Neuronetics Inc  expected to post a loss of13cents a share - Earnings Preview Neuronetics Inc STIM.OQ STIM.O is expected to  show a rise in quarterly revenue when it reports  results on November 4 for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL8N3WC1HS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","STIM"],"gpt_icon":0},{"id":"2579967141","title":"Neuronetics Inc - Partnership Pilot Launched in Q4 2025, Expansion Planned for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2579967141","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579967141?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:32","pubTimestamp":1761827520,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUA8PLPMR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STIM","BK4082"],"gpt_icon":0},{"id":"2579141575","title":"Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence","url":"https://stock-news.laohu8.com/highlight/detail?id=2579141575","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579141575?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:32","pubTimestamp":1761827520,"startTime":"0","endTime":"0","summary":"New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA ClinicsMALVERN, Pa., Oct.  30, 2025  (GLOB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/30/3177422/0/en/Neuronetics-Announces-Three-Year-Exclusive-Partnership-with-Elite-DNA-Behavioral-Health-to-Expand-NeuroStar-Access-and-Operational-Excellence.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4121","DNA","BK4139","STIM","BK4109","ABVC"],"gpt_icon":0},{"id":"2568496458","title":"Neuronetics Inc - Coverage Effective Oct 1 for Fee-for-Service Medicaid Members","url":"https://stock-news.laohu8.com/highlight/detail?id=2568496458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568496458?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:41","pubTimestamp":1758112879,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nFWN3V40I4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STIM","BK4082"],"gpt_icon":0},{"id":"2568109496","title":"Neuronetics Inc - New York Medicaid to Cover Tms Services for Adults With Mdd","url":"https://stock-news.laohu8.com/highlight/detail?id=2568109496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568109496?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:41","pubTimestamp":1758112879,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nFWN3V40I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","STIM"],"gpt_icon":0},{"id":"2568496179","title":"Neuronetics announces New York State Medicaid to begin covering TMS services","url":"https://stock-news.laohu8.com/highlight/detail?id=2568496179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568496179?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:35","pubTimestamp":1758112533,"startTime":"0","endTime":"0","summary":"Neuronetics (STIM) announced that New York State Medicaid will begin covering Transcranial Magnetic Simulation, TMS, services for adults diagnosed ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neuronetics-announces-new-york-state-medicaid-to-begin-covering-tms-services-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neuronetics-announces-new-york-state-medicaid-to-begin-covering-tms-services-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3QW5Z07.USD","BK4082","STIM","IE0034235188.USD","BK4585","LU1894683264.USD","IE00B64PRP62.GBP","LU1883839398.USD","BK4135","LU1894683348.USD","BK4588","LU0061475181.USD","IE00BGHQF748.EUR","STT"],"gpt_icon":0},{"id":"2568349613","title":"New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568349613","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568349613?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:32","pubTimestamp":1758112320,"startTime":"0","endTime":"0","summary":"Over 5 million New York Medicaid members to gain access to Transcranial Magnetic Stimulation (TMS) servicesMALVERN, Pa., Sept.  17, 2025  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medica","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/17/3151639/0/en/New-York-State-Medicaid-Expands-Coverage-for-TMS-Therapy-Including-NeuroStar-Advanced-Therapy-to-Treat-Major-Depressive-Disorder-MDD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1883839398.USD","LU1894683348.USD","BK4585","BK4588","IE00B64PRP62.GBP","STT","BK4139","ABVC","LU0061475181.USD","IE00B3QW5Z07.USD","BK4082","STIM","BK4135","LU1894683264.USD","IE00BGHQF748.EUR","IE0034235188.USD"],"gpt_icon":0},{"id":"2559900621","title":"Madryn Asset Management, LP Reports Disposal of Neuronetics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559900621","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559900621?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:16","pubTimestamp":1755029760,"startTime":"0","endTime":"0","summary":"Madryn Asset Management, LP, along with other reporting beneficial owners, reported a disposal of common shares of Neuronetics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuronetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL7ysx53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","STIM"],"gpt_icon":0},{"id":"2557300797","title":"Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2557300797","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557300797?lang=en_us&edition=fundamental","pubTime":"2025-08-07 04:45","pubTimestamp":1754513100,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Aug.  06, 2025  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/06/3128754/0/en/Neuronetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","BK4588","LU0314104364.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","ABVC","BK4139","BK4082","IE00B64PRP62.GBP","LU2095319765.USD","LU2210150020.SGD","NDAQ","LU2210149790.SGD",".IXIC","STIM","IE00BKPKM429.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurostar.com","stockEarnings":[{"period":"1week","weight":0.1259},{"period":"1month","weight":-0.2963},{"period":"3month","weight":-0.5136},{"period":"6month","weight":-0.5989},{"period":"1year","weight":0.3103},{"period":"ytd","weight":-0.0559}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.148078},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.021193},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.115078},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.034983},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.075947},{"month":6,"riseRate":0.571429,"avgChangeRate":0.019502},{"month":7,"riseRate":0.5,"avgChangeRate":0.076613},{"month":8,"riseRate":0.25,"avgChangeRate":-0.019348},{"month":9,"riseRate":0,"avgChangeRate":-0.13161},{"month":10,"riseRate":0.5,"avgChangeRate":-0.012062},{"month":11,"riseRate":0.375,"avgChangeRate":0.083783},{"month":12,"riseRate":1,"avgChangeRate":0.235537}],"exchange":"NASDAQ","name":"Neuronetics Inc.","nameEN":"Neuronetics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neuronetics Inc.(STIM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Neuronetics Inc.(STIM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Neuronetics Inc.,STIM,Neuronetics Inc.股票,Neuronetics Inc.股票老虎,Neuronetics Inc.股票老虎国际,Neuronetics Inc.行情,Neuronetics Inc.股票行情,Neuronetics Inc.股价,Neuronetics Inc.股市,Neuronetics Inc.股票价格,Neuronetics Inc.股票交易,Neuronetics Inc.股票购买,Neuronetics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neuronetics Inc.(STIM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Neuronetics Inc.(STIM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction